Antibodies to the soluble ribonucleoprotein (Ro(SSA))' extractable cellular antigen occur predominantly in patients with primary Sjogren's syndrome (SS)>4 and systemic lupus erythematosus (SLE),s particularly in seronegative lupus,6 subacute lupus,7 and lu us patients with histological manifestations of SS. This antibody has also been described in rheumatoid arthritis (RA) patients with sicca syndrome9 and in some patients with systemic sclerosis.'0 In a recent Greek study this antibody occurred in 25% of SLE patients, in approximately 10% of scleroderma patients, in 40% of SS patients, and in 15% of RA patients. A major feature was that anti-Ro positive RA patients experienced a high frequency of D-penicillamine side effects."
In this study we compare the clinical, laboratory, histological, and radiological manifestations of antiRo(SSA) positive RA patients with those of antiRo(SSA) negative RA patients and examine the response of the two groups to penicillamine treatment. (Tables 1   and 2 ). The admission rheumatoid factor (RF) titres, serum C-reactive protein (CRP) levels, erythrocyte sedimentation rate, anaemia (Hb<9 g/dl), leucopenia (leucocytes<4x 109/1), and thrombocytopenia (platelets<100x 109/l) were also analysed (Table 3) .
Finally, effectiveness and side effects of penicillamine treatment were recorded (Table 4) . Seventeen anti-Ro negative RA patients and nine anti-Ro positive RA patients were evaluated for interstitial lung disease with a respiratory questionnaire,14 physical examination, chest roentgenogram, spirometry, and arterial blood gas analysis. We considered the presence of positive findings in at least two of the three parameters: clinical, roentgenological, and functional, to be evidence of diffuse interstitial lung disease.
The hand x-rays of 30 anti-Ro(SSA) negative and anti-Ro(SSA) positive RA patients were reviewed without knowledge of other clinical or serological features using the grading system proposed by Larsen (Table 5 ). 15 The presence of at least one lesion of a particular grade at any location on either hand was used for grading.
Labial minor salivary glands were biopsied randomly on 42 anti-Ro(SSA) negative RA patients and 13 anti-Ro(SSA) positive patients. Haematoxylin and eosin stained slides were blindly read and graded according to Tarpley's classification. 16 Only biopsy specimens with infiltrates greater than 2+ were considered positive.
For statistical analysis the X2 test and Student's ttest were used. 
Results
factor titre (t=2-62, p<0.01) which was lower in the anti-Ro(SSA) positive group. The severity of the The male to female ratio, the mean age, the disease radiological erosions tended to be greater in the duration, and duration of follow up of the two anti-Ro(SSA) positive group, though this difference groups of patients are given in Table 1 . The only did not reach statistical significance (Table 5) . difference was that anti-Ro(SSA) positive RA Forty-seven anti-Ro(SSA) negative RA patients patients were predominantly females, while anti-and 13 anti-Ro(SSA) positive RA patients were Ro(SSA) negative RA affected males to females in a treated with D-penicillamine for more than six 1:3 ratio. months (mean duration follow up was 13*8 months).
The incidence of articular and extra-articular The D-penicillamine dose did not exceed 500 mg manifestations and the histological changes in the daily. Eight of the 13 anti-Ro(SSA) positive RA minor salivary glands of the two groups ofpatients are patients developed side effects within six months of given in Table 2 . The pattern of arthritis and the treatment, consisting primarily of skin rashes, incidence of extra-articular manifestations were decreased taste sensation, fever, leucopenia, and similar, while anti-Ro(SSA) positive RA patients proteinuria. In contrast 4/47 anti-Ro(SSA) negative more often had lymphoid infiltrates in the labial RA patients developed side effects. One of these salivary gland biopsy specimens compared with the patients developed proteinuria, another myasthenia anti-Ro(SSA) negative group. gravis, and two patients had loss of taste sensation
The only laboratory parameter which differed (Table 4) . Table 6 shows the side effects in the significantly (Table 3) was the serum rheumatoid Ro(SSA) positive group in more detail. 
Discussion
In the last decade studies on the antibodies to cellular (nuclear and cytoplasmic) antigens have provided additional diagnostic, prognostic, and pathogenetic clues for the autoimmune rheumatic diseases. 17 Our study showed that Greek RA patients have a higher incidence of antibodies to Ro(SSA) cellular antigen compared with that of other RA patient groups tested by the same method.2 1 The high incidence of antibodies to Ro(SSA) cellular antigen in Greek RA patients points towards two possibilities: either Greek anti-Ro(SSA) positive RA patients possess a genetic make up which predisposes them to develop this clinicoserological picture or the environmental factor which triggers this subset of RA is more common in Greece.
Alexander et al.9 linked the presence of antiRo(SSA) with the development of Sjogren's syndrome, but no comment was made about the other differences between the anti-Ro(SSA) positive and anti-Ro(SSA) negative RA patients. We have also found an association with Sjogren's syndrome, but in this study anti-Ro(SSA) positive RA It can be postulated that penicillamine-induced immunosuppression in RA patients with more aggressive autoimmune disease (lymphocytic infiltration of the exocrine glands, anti-Ro(SSA) antibody, leucopenia, etc.) further distorts the already aberrant immunoregulation of these patients, resulting in additional immunological side effects, such as skin rashes, fever, and proteinuria.
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